Where Edgewise Therapeutics Stands With Analysts
Portfolio Pulse from Benzinga Insights
Edgewise Therapeutics (NASDAQ:EWTX) has received positive analyst ratings in the last quarter, with 2 bullish and 4 somewhat bullish ratings. The average price target for the stock is $26.17, a significant increase from its current price of $7.06. This average has increased by 9.04% from the previous average price target of $24.00.
August 16, 2023 | 3:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Edgewise Therapeutics has received positive analyst ratings, indicating potential growth. The average price target suggests a significant upside from the current price.
Analyst ratings are a key indicator of a stock's potential performance. The positive ratings for Edgewise Therapeutics, along with an increased average price target, suggest that analysts expect the stock to perform well in the future. This could lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100